TSX:OGC
TSX:OGCMetals and Mining

Did OceanaGold's Strong Q2 and Buyback Completion Just Shift Its (TSX:OGC) Investment Narrative?

OceanaGold Corporation recently announced strong second-quarter results, reporting sales of US$432.4 million and net income of US$114.1 million, alongside higher gold and copper production, a dividend increase, and completion of its major share buyback program. These developments mark significant operational and financial progress, reflecting enhanced shareholder returns and management changes amid robust production and capital discipline. We'll explore how the company's sharply improved...
NasdaqGS:DVAX
NasdaqGS:DVAXBiotechs

Is Dynavax Technologies' (DVAX) Raised HEPLISAV-B Guidance Reshaping Its Investment Narrative?

Earlier this month, Dynavax Technologies Corporation raised its full-year 2025 revenue guidance for HEPLISAV-B to a range of US$315 million to US$325 million and posted quarterly results showing second-quarter revenue climbed to US$95.44 million, with net income reaching US$18.72 million. The guidance increase reflects strong performance in the first half, while the earnings report highlights significant year-over-year growth in both revenue and profit margins for the company. To understand...
NYSE:KVUE
NYSE:KVUEPersonal Products

Did Kenvue's (KVUE) Guidance Cut and Leadership Shift Signal a Change in Long-Term Strategy?

Kenvue recently reported its second-quarter 2025 earnings, with net income rising to US$420 million from US$58 million a year earlier, while sales declined to US$3,839 million from US$4,000 million; the company also revised its full-year 2025 guidance, now expecting net and organic sales to be down low-single-digits. Alongside the financial update, Kenvue announced the appointment of a new Chief Technology & Data Officer and completed a significant share buyback, indicating both leadership...
NYSE:VVX
NYSE:VVXAerospace & Defense

Why V2X (VVX) Is Up 21.2% After Follow-On Equity Offering Following Profitability Turnaround

Earlier this month, V2X, Inc. filed for a follow-on equity offering of 2,000,000 shares of common stock shortly after reporting a return to profitability in its second-quarter results and reaffirming its full-year revenue guidance. This sequence of events highlights how the company is taking advantage of renewed financial momentum to strengthen its balance sheet through equity financing. We'll explore how V2X’s follow-on equity offering, coming right after its profitability turnaround, may...
NYSE:CTEV
NYSE:CTEVHealthcare Services

Claritev (CTEV) Shifts Revenue Forecasts—Is Its Global Expansion Strategy Hitting an Inflection Point?

In the past week, Claritev Corporation reported second-quarter results showing higher sales at US$241.57 million and a sharply reduced net loss of US$62.64 million, while updating its full-year 2025 revenue guidance to between flat and 2% growth from 2024 levels. The company’s US$400 million universal shelf registration, covering a range of securities, adds financial flexibility to support potential future initiatives and growth plans. We will explore how Claritev’s improving financial...
TSX:SIS
TSX:SISMachinery

Savaria’s Q2 Net Income Surge Might Change The Case For Investing In Savaria (TSX:SIS)

On August 6, 2025, Savaria Corporation reported its second-quarter and half-year results, showing sales growth to CA$226.75 million and CA$446.98 million, respectively, along with improved net income and earnings per share compared to the previous year. An important insight from these results is the considerable increase in net income for both periods, reflecting operational improvements and stronger profitability initiatives at the company. We'll examine how Savaria's jump in net income and...
TSX:IMG
TSX:IMGMetals and Mining

Why IAMGOLD (TSX:IMG) Is Up 8.7% After Raising 2025 Production Guidance and Posting Record Sales

IAMGOLD Corporation recently released its second quarter 2025 results, reporting increased gold production and sales alongside updated full-year production guidance of 735,000 to 820,000 ounces. Despite higher revenues, the company recorded slightly lower net income and earnings per share compared to the previous year. The combination of record gold sales and production growth positions IAMGOLD at a pivotal point as it targets expanded operational output for the remainder of 2025. We’ll...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Will Vera Therapeutics' (VERA) Major Equity Raise Reshape Its Resilience Amid Mounting Losses?

Vera Therapeutics recently reported a second quarter net loss of US$76.53 million, significantly higher than a year ago, and announced a US$200 million follow-on equity offering of Class A common stock. The concurrent disclosure of increased quarterly losses and a major capital raise highlights potential funding needs and ongoing operational pressures facing the company. We’ll examine how Vera Therapeutics’ expanded capital raise shapes its investment narrative amid growing financial...